NCT05914740

Brief Summary

In this project, an exploratory study was conducted to perform in situ venous valve remodeling in vivo, evaluate venous valve function after surgery and conduct regular follow-up, collect relevant ultrasonic data before, during and after surgery, and evaluate the safety and effectiveness of Ultrasound-guided percutaneous great saphenous vein valve functional remodeling.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 19, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 24, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

9 months

First QC Date

May 24, 2023

Last Update Submit

June 19, 2023

Conditions

Keywords

Varicose veins in the lower extremitiesUltrasonic guidancevenous valve of Lower limb

Outcome Measures

Primary Outcomes (12)

  • Venous valve regurgitation or not

    Under the calf compression test, the venous valves were observed for blood flow regurgitation signal

    immediately after intervention

  • Venous valve regurgitation or not

    Under the calf compression test, the venous valves were observed for blood flow regurgitation signal

    1 week after intervention

  • Venous valve regurgitation or not

    Under the calf compression test, the venous valves were observed for blood flow regurgitation signal

    1 month after intervention

  • Venous valve regurgitation or not

    Under the calf compression test, the venous valves were observed for blood flow regurgitation signal

    3 months after intervention

  • Venous valve regurgitation or not

    Under the calf compression test, the venous valves were observed for blood flow regurgitation signal

    6 months after intervention

  • Venous valve regurgitation or not

    Under the calf compression test, the venous valves were observed for blood flow regurgitation signal

    1 year after intervention

  • Changes in the duration of venous valve regurgitation

    The duration of venous valve regurgitation was measured under calf compression test

    immediately after intervention

  • Changes in the duration of venous valve regurgitation

    The duration of venous valve regurgitation was measured under calf compression test

    1 week after intervention

  • Changes in the duration of venous valve regurgitation

    The duration of venous valve regurgitation was measured under calf compression test

    1 month after intervention

  • Changes in the duration of venous valve regurgitation

    The duration of venous valve regurgitation was measured under calf compression test

    3 months after intervention

  • Changes in the duration of venous valve regurgitation

    The duration of venous valve regurgitation was measured under calf compression test

    6 months after intervention

  • Changes in the duration of venous valve regurgitation

    The duration of venous valve regurgitation was measured under calf compression test

    1 year after intervention

Study Arms (1)

Venous valve remodeling

EXPERIMENTAL

Venous valve function was remodeled under ultrasound guidance

Procedure: Ultrasound guided functional remodeling of lower extremity superficial vein valve

Interventions

Preoperative ultrasound was used to re-evaluate and confirm the valve function, disinfect the tissue, inject hyaluronic acid around the great saphenous vein valve to reshape the valve about 1-2ml, monitor the whole process under ultrasound, pump back for protection during injection, and inject multiple times at different points.

Venous valve remodeling

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-80, gender unlimited
  • CEAP grading was C2-C5 patients
  • The patient was clinically diagnosed as a primary varicose great saphenous vein of lower extremity, and the ultrasound findings were great saphenous vein valve insufficiency (complete structure, normal shape, enlarged valve ring, Duration of reflux \>0.5s), only unilateral varicose great saphenous vein was treated this time

You may not qualify if:

  • Patients with target vessel diameter \< 3mm
  • The final valve of the great saphenous vein was not clear or lost its normal shape on ultrasound
  • Patients with deep vein valvular insufficiency
  • The presence of thrombus or thrombophlebitis in the main trunk of great cryptic skin
  • Target diseased blood vessel had previously received surgical treatment
  • Patients with deep vein thrombosis or history of pulmonary distension embolism
  • Patients with active implants such as pacemakers or ICDs
  • Patients with severe abnormal liver and kidney function (more than three times the normal value)
  • Patients with non-primary varicose veins caused by post-deep vein thrombosis syndrome, Cockett syndrome (iliac vein compression syndrome), KT syndrome (venous malformation hypertrophy syndrome \>, arteriovenous sputum, etc
  • Any serious or uncontrolled systemic disease (including poorly medicated hypertension, diabetes, and diseases with active bleeding signs or severe coagulopathy)
  • Patients with diseases that may make treatment and evaluation difficult (e.g., malignant arsine tumor, acute infectious diseases, sepsis, systemic intolerability of surgery, life expectancy less than 12 months, etc.)
  • Pregnant and lactating women, or those who planned to have children during the study period
  • Patients who have participated in clinical trials of other drugs or medical devices within the last 3 months
  • Anesthetist and other patients were deemed unsuitable for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Fourth Affiliated Hospital Zhejiang University School of Medicine

Yiwu, Zhejiang Procince, 322000, China

RECRUITING

Related Publications (2)

  • De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, Giannoukas A, Gohel M, de Graaf R, Hamel-Desnos C, Jawien A, Jaworucka-Kaczorowska A, Lattimer CR, Mosti G, Noppeney T, van Rijn MJ, Stansby G, Esvs Guidelines Committee, Kolh P, Bastos Goncalves F, Chakfe N, Coscas R, de Borst GJ, Dias NV, Hinchliffe RJ, Koncar IB, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, Bjorck M, Labropoulos N, Lurie F, Mansilha A, Nyamekye IK, Ramirez Ortega M, Ulloa JH, Urbanek T, van Rij AM, Vuylsteke ME. Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022 Feb;63(2):184-267. doi: 10.1016/j.ejvs.2021.12.024. Epub 2022 Jan 11. No abstract available.

  • Muhlberger D, Brenner E, Frings N, Geier B, Mumme A, Reich-Schupke S, Steffen HP, Stenger D, Stucker M, Hummel T. Functional repair of the great saphenous vein by external valvuloplasty reduces the vein's diameter: 6-month results of a multicentre study. J Int Med Res. 2021 May;49(5):3000605211014364. doi: 10.1177/03000605211014364.

Study Officials

  • Yuefeng Zhu, Master's

    The Fourth Affiliated Hospital Zhejiang University School of Medicine

    STUDY DIRECTOR

Central Study Contacts

Yuefeng Zhu, Master's

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Open trial
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A certain number of patients meeting the requirements (meeting the inclusion criteria, but not meeting the exclusion criteria) were selected for preoperative hemodynamic evaluation of lower extremity vein ultrasound to determine the reflux points and reflux points, identify the blood circulation pattern, and design an individualized surgical program. Intraoperative venous valve was reconstructed in situ under ultrasound guidance. Postoperative ultrasound was used to assess venous valve function and complications in the operative area.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2023

First Posted

June 22, 2023

Study Start

April 19, 2023

Primary Completion

December 31, 2023

Study Completion

July 30, 2024

Last Updated

June 22, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations